Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs SOURCE NATURAL FOODS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA SOURCE NATURAL FOODS AJANTA PHARMA/
SOURCE NATURAL FOODS
 
P/E (TTM) x 38.3 22.5 170.3% View Chart
P/BV x 8.3 3.2 259.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AJANTA PHARMA   SOURCE NATURAL FOODS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
SOURCE NATURAL FOODS
Mar-23
AJANTA PHARMA/
SOURCE NATURAL FOODS
5-Yr Chart
Click to enlarge
High Rs1,426189 755.0%   
Low Rs1,06279 1,353.1%   
Sales per share (Unadj.) Rs297.230.7 967.5%  
Earnings per share (Unadj.) Rs46.73.3 1,417.9%  
Cash flow per share (Unadj.) Rs57.14.0 1,439.5%  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.127.5 978.0%  
Shares outstanding (eoy) m125.916.44 1,955.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.24.3 96.2%   
Avg P/E ratio x26.640.6 65.7%  
P/CF ratio (eoy) x21.833.7 64.7%  
Price / Book Value ratio x4.64.9 95.2%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,638860 18,204.1%   
No. of employees `000NANA-   
Total wages/salary Rs m7,85131 25,028.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,426198 18,915.6%  
Other income Rs m9860 657,600.0%   
Total revenues Rs m38,413198 19,400.4%   
Gross profit Rs m7,83335 22,125.7%  
Depreciation Rs m1,3084 30,207.9%   
Interest Rs m584 1,513.0%   
Profit before tax Rs m7,45327 27,238.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5736 25,572.4%   
Profit after tax Rs m5,88021 27,721.8%  
Gross profit margin %20.917.9 117.0%  
Effective tax rate %21.122.5 93.9%   
Net profit margin %15.710.7 146.5%  
BALANCE SHEET DATA
Current assets Rs m28,252168 16,809.5%   
Current liabilities Rs m11,39334 33,283.1%   
Net working cap to sales %45.067.6 66.6%  
Current ratio x2.54.9 50.5%  
Inventory Days Days661 5,406.9%  
Debtors Days Days101,367 0.8%  
Net fixed assets Rs m18,70746 40,237.7%   
Share capital Rs m25364 392.6%   
"Free" reserves Rs m33,624113 29,808.3%   
Net worth Rs m33,877177 19,120.9%   
Long term debt Rs m130 31,250.0%   
Total assets Rs m47,047215 21,928.0%  
Interest coverage x128.68.1 1,590.1%   
Debt to equity ratio x00 163.4%  
Sales to assets ratio x0.80.9 86.3%   
Return on assets %12.611.7 108.0%  
Return on equity %17.412.0 145.0%  
Return on capital %22.217.6 125.8%  
Exports to sales %59.90.5 12,074.9%   
Imports to sales %11.50-   
Exports (fob) Rs m22,4201 2,287,775.5%   
Imports (cif) Rs m4,293NA-   
Fx inflow Rs m22,4201 2,287,775.5%   
Fx outflow Rs m4,2930-   
Net fx Rs m18,1271 1,849,704.1%   
CASH FLOW
From Operations Rs m7,91825 31,507.4%  
From Investments Rs m-5,5961 -999,285.7%  
From Financial Activity Rs m-1,079-5 20,468.7%  
Net Cashflow Rs m1,24320 6,090.6%  

Share Holding

Indian Promoters % 66.2 74.4 89.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 0.0 -  
FIIs % 9.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 25.6 131.8%  
Shareholders   54,351 3,271 1,661.6%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs INWINEX PHARMA.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs INWINEX PHARMA. Share Price Performance

Period AJANTA PHARMA INWINEX PHARMA. S&P BSE HEALTHCARE
1-Day 2.51% -1.08% 1.18%
1-Month 7.60% -8.23% -0.75%
1-Year 92.91% -3.07% 61.82%
3-Year CAGR 21.63% -15.19% 18.16%
5-Year CAGR 26.85% 15.41% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the INWINEX PHARMA. share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of INWINEX PHARMA. the stake stands at 74.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of INWINEX PHARMA..

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

INWINEX PHARMA. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of INWINEX PHARMA..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.